Search filters

List of works by Carmela Coppola

Antineoplastic-related cardiotoxicity, morphofunctional aspects in a murine model: contribution of the new tool 2D-speckle tracking.

scientific article

Cardioprotective Effects of Nanoemulsions Loaded with Anti-Inflammatory Nutraceuticals against Doxorubicin-Induced Cardiotoxicity

scientific article published on 14 September 2018

Cardiotoxic effects of the novel approved anti-ErbB2 agents and reverse cardioprotective effects of ranolazine.

scientific article published on 19 April 2018

Cardiotoxicity and pro-inflammatory effects of the immune checkpoint inhibitor Pembrolizumab associated to Trastuzumab

scientific article published on 17 May 2019

Cardiotoxicity from anthracycline and cardioprotection in paediatric cancer patients

scientific article published on May 2016

Comparison of preclinical cardiotoxic effects of different ErbB2 inhibitors.

scientific article published on 27 September 2011

Effects of a second-generation human anti-ErbB2 ImmunoRNase on trastuzumab-resistant tumors and cardiac cells

scientific article published on 12 January 2014

Low doses of Bisphenol A have pro-inflammatory and pro-oxidant effects, stimulate lipid peroxidation and increase the cardiotoxicity of Doxorubicin in cardiomyoblasts

scientific article published on 07 March 2019

Management of QT prolongation induced by anti-cancer drugs: Target therapy and old agents. Different algorithms for different drugs

scientific article

Metabolic syndrome-breast cancer link varies by intrinsic molecular subtype

scientific article

Pathophysiology of cardiotoxicity from target therapy and angiogenesis inhibitors.

scientific article published on May 2016

Ranolazine Attenuates Trastuzumab-Induced Heart Dysfunction by Modulating ROS Production

scientific article published on 6 February 2018

Ranolazine protects from doxorubicin-induced oxidative stress and cardiac dysfunction.

scientific article published in April 2014

The Long Non-Coding RNA Prader Willi/Angelman Region RNA5 (PAR5) Is Downregulated in Anaplastic Thyroid Carcinomas Where It Acts as a Tumor Suppressor by Reducing EZH2 Activity

scientific article published on 17 January 2020

The emerging issue of cardiac dysfunction induced by antineoplastic angiogenesis inhibitors ⬇️

scientific article published on January 16, 2013

Trastuzumab and target-therapy side effects: Is still valid to differentiate anthracycline Type I from Type II cardiomyopathies?

scientific article published on 02 February 2016

Paulina is supported by:

About Paulina

Help